haematological malignancies
Showing 1 - 7 of 7
Haematological Malignancies Trial in Worldwide (AZD0466, Voriconazole)
Recruiting
- Haematological Malignancies
-
Scottsdale, Arizona
- +34 more
Dec 15, 2022
Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)
Completed
- Haematological Malignancies
- CD25/71 allodepleted donor T-cells
-
London, United Kingdom
- +1 more
Jul 18, 2022
Lateral Flow Immunoassays for Detection of SARS-CoV-2 Antibodies
Recruiting
- Solid Organ Transplant Recipients
- +2 more
- self-administered lateral flow assays
-
Bristol, United Kingdom
- +3 more
May 25, 2022
Haematological Malignancies, CMV Infection Trial in United Kingdom (CMV-TCR transduced donor-derived T cells)
Suspended
- Haematological Malignancies
- CMV Infection
- CMV-TCR transduced donor-derived T cells
-
Birmingham, United Kingdom
- +3 more
Sep 10, 2018
Haematological Malignancies, Allogeneic Stem Cell Transplant, CD56+CD3- NK Cells Trial in London (Infusion of donor derived
Withdrawn
- Haematological Malignancies
- +2 more
- Infusion of donor derived ex-vivo selected NK cells to patients after transplant
- Haematology / Blood chemistry sampling
-
London, United KingdomHammersmith Hospital
Jun 3, 2015
Non-Myeloablative Haplo-identical Haematopoietic Stem Cell
Unknown status
- Haematological Malignancies
- Acquired Aplastic Anaemia
-
Singapore, SingaporeNational University Hospital
Dec 10, 2013